Current Research Programs

Our state-of-the-art facility plays a crucial role in ongoing research alongside our active care programs. A list of our current programs are below.

EMDMA-001: MDMA-assisted therapy of PTSD

  • Status: Active
  • Investigational Treatment: MDMA-assisted therapy for PTSD
  • Phase: Observational, Open-Label
  • Indication: Post-Traumatic Stress Disorder
  • This study is looking for patients who have the following:
    • Aged between 18-85 years old
    • Current diagnosis of PTSD
    • Failed at least one treatment for PTSD (either psychotherapy or pharmacological treatment)

Reach Wellness Study of MDMA-AT for First Responders

  • Status: In planning
  • Investigational Treatment: MDMA-assisted therapy for PTSD
  • Phase: Observational, Open-Label
  • Indication: Post-Traumatic Stress Disorder
  • This study is looking for patients who have the following:
    • Aged between 18-65 years old
    • Current diagnosis of PTSD
    • Currently serving or recent first responder